Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma
- 1 May 1985
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 15 (1) , 66-71
- https://doi.org/10.1007/bf00257298
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- STRIPE: An interactive computer program for the analysis of drug pharmacokineticsJournal of Pharmacological Methods, 1983
- FURTHER ADVANCES IN THE MANAGEMENT OF MALIGNANT TERATOMAS OF THE TESTIS AND OTHER SITESThe Lancet, 1983
- Pharmacokinetic Principles of Antineoplastic Drug TherapyThe Journal of Clinical Pharmacology, 1983
- Clinical Pharmacokinetics of Commonly Used Anticancer DrugsClinical Pharmacokinetics, 1983
- VP16-213 as a single agent in advanced testicular tumorsPublished by Elsevier ,1980
- Anti-tumour activity of the epipodophyllin derivative VP16–213 (etoposide: NSC-141540) in gestational choriocarcinomaPublished by Elsevier ,1980
- In vivo Metabolite-antimetabolite relationships in antitumor therapyAdvances in Enzyme Regulation, 1978
- EPIPODOPHYLLIN DERIVATIVE (VP 16-213) IN MALIGNANT TERATOMAS AND CHORIOCARCINOMASThe Lancet, 1977
- Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivativesPublished by Elsevier ,1975
- SCHEDULE DEPENDENCY OF THE ANTILEUKEMIC ACTIVITY OF THE PODOPHYLLOTOXIN‐DERIVATIVE VP 16–213 (NSC‐141540) IN L1210 LEUKEMIAActa Pathologica Microbiologica Scandinavica Section A Pathology, 1973